title: [A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis].
abstract: A 62-year-old male patient was admitted for spontaneous rupture of hepatocellular carcinoma. He also had multiple lung metastases and liver dysfunction. So neither operation nor trans-arterial embolization could be performed. He had been administered UFT (400 mg/day) orally every day. After 5 months of daily administration, there was complete disappearance of multiple lung metastasis and reduction of the primary tumor. This case suggests that UFT is effective for some advanced hepatocellular carcinoma with extrahepatic metastasis.
authors.affiliation: Division of Gastroenterological Surgery, Chiba Cancer Center Hospital, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Tsurumachi
authors.forename: H
authors.initials: H
authors.lastname: Yamamoto
authors.forename: K
authors.initials: K
authors.lastname: Watanabe
authors.forename: I
authors.initials: I
authors.lastname: Honda
authors.forename: S
authors.initials: S
authors.lastname: Watanabe
authors.forename: S
authors.initials: S
authors.lastname: Yamada
authors.forename: K
authors.initials: K
authors.lastname: Jingu
authors.forename: D
authors.initials: D
authors.lastname: Satomi
authors.forename: M
authors.initials: M
authors.lastname: Fujita
mesh_terms: D000284:Administration, Oral; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000556:secondary*; D004338:Drug Combinations; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary*; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D005641:Tegafur / Q000627:therapeutic use*; D014498:Uracil / Q000627:therapeutic use*
chemical_list: D004338:Drug Combinations; C096910:UFT(R) drug; D005641:Tegafur; D014498:Uracil